The Trying Trap: The single most damaging mistake an insomniac makes is treating sleep as something they need to work at. Sleep is not an achievement; it is the absence of arousal. The harder you try to fall asleep, the more activated your nervous system becomes — and the further from sleep you drift. Modern sleep medicine has now formalised this paradox as the hyperarousal model of insomnia, and the treatment that emerges is the opposite of what most exhausted adults instinctively reach for.
The mainstream clinical model of chronic insomnia for most of the 20th century focused on sleep itself — too little of it, too poorly structured, too easily disrupted. The modern view, articulated most clearly by researchers including Michael Perlis at the University of Pennsylvania, reframes chronic insomnia as fundamentally a state of physiological and cognitive hyperarousal. Insomniacs are not failing to sleep; they are sustaining a level of nervous-system activation that is incompatible with sleep onset and maintenance [cite: Perlis et al., Sleep Med Clin, 2010].
The implication transforms the treatment landscape. If the underlying problem is hyperarousal rather than sleep failure, the correct interventions are those that reduce arousal — not those that increase the time and effort spent in bed trying to sleep. The clinical evidence has now caught up. The first-line treatment for chronic insomnia, recommended by the American College of Physicians, is not medication. It is cognitive behavioural therapy for insomnia (CBT-I), which addresses the hyperarousal directly.
1. The Three Hyperarousal Domains
Modern sleep research distinguishes three distinct hyperarousal systems that contribute to chronic insomnia:
- Physiological Hyperarousal: Elevated cortisol, increased sympathetic tone, higher core body temperature, and faster baseline heart rate compared to healthy sleepers.
- Cognitive Hyperarousal: Persistent mental activity — planning, worrying, replaying — that competes with sleep onset and intrudes on light sleep.
- Conditioned Hyperarousal: Bed and bedroom have become associated with frustration, effort, and failure, producing automatic arousal at the very environmental cues that should support sleep.
Each domain is reinforced by the others. The bed becomes associated with effort because of cognitive intrusion; the cognitive intrusion is amplified by physiological elevation; the physiological elevation is sustained by the chronic conditioned response to the bedroom itself.
The Bonnet-Arand Studies: Insomniacs Are Aroused Even During Sleep
One of the most striking pieces of evidence for the hyperarousal model came from work by Michael Bonnet and Donna Arand at Wright State University in the 1990s and 2000s. Using continuous physiological monitoring during sleep itself, the team documented that chronic insomniacs maintain elevated heart rate, elevated metabolic rate, and elevated EEG-detectable arousal indicators compared to healthy sleepers — even during the periods when they are objectively asleep. The hyperarousal does not disappear when sleep is achieved; it persists across the night, accounting for the chronic feeling that the sleep insomniacs do manage to get feels “unrefreshing” relative to the same duration in healthy sleepers [cite: Bonnet & Arand, Psychosom Med, 1995].
2. Why “Just Get More Sleep” Is the Wrong Treatment
The standard intuition for treating insomnia — go to bed earlier, stay in bed longer, prioritise sleep — is, on the clinical evidence, often counterproductive. Spending more time in bed allows the conditioned hyperarousal to deepen and produces longer periods of unsuccessful sleep effort that reinforce the bedroom-as-failure-zone association.
The counterintuitive but well-validated treatment is the opposite: sleep restriction therapy. By deliberately limiting time in bed to the actual sleep duration the patient currently achieves (with strict bed and rise times), the protocol increases sleep efficiency, reduces conditioned arousal, and gradually rebuilds a healthy bed-sleep association. The treatment is uncomfortable in the first weeks but consistently outperforms longer-time-in-bed strategies on every measured outcome.
| Insomnia Intervention | Mechanism | Evidence Strength |
|---|---|---|
| CBT-I (Full Programme) | Addresses all three arousal domains. | First-line; comparable to medication short-term, superior long-term. |
| Sleep Restriction Therapy | Compresses time in bed; reduces conditioned arousal. | Strong; core component of CBT-I. |
| Stimulus Control | Rebuilds bed-sleep association. | Strong; well-replicated. |
| Cognitive Restructuring | Addresses worry-driven cognitive arousal. | Moderate; complementary to behavioural elements. |
| Z-Drugs (Ambien etc.) | Pharmacological sedation. | Short-term symptom relief; problematic long-term. |
3. The Sleeping Pill Trap
The pharmaceutical sleep market is enormous and growing. Z-drugs (zolpidem, eszopiclone) and benzodiazepines remain among the most-prescribed classes of medication in developed countries. The clinical evidence for their long-term use, however, has substantially weakened over the past decade.
Several issues have emerged:
- Tolerance: Effectiveness declines with sustained use, leading to dose escalation.
- Sleep Architecture Disruption: Z-drug-induced sleep often lacks the normal architecture of natural sleep, particularly affecting deep slow-wave sleep.
- Withdrawal Insomnia: Discontinuation often produces rebound insomnia worse than the original complaint.
- Cognitive Side Effects: Long-term Z-drug use has been associated with cognitive impairment and elevated dementia risk in some cohort studies.
The implication is not that sleep medication is universally inappropriate. It has clear roles in acute, short-term insomnia and in specific clinical contexts. But the chronic-insomnia treatment paradigm has shifted decisively toward CBT-I as first-line, with medication as adjunct rather than primary therapy.
4. How to Apply Hyperarousal Reduction in Daily Life
The protocols below capture the core CBT-I principles in actionable form for adults experiencing chronic sleep difficulty.
- Stimulus Control: Use the bed only for sleep and sex. If unable to sleep within 20 minutes, leave the bed, return only when sleepy.
- Sleep Restriction: Restrict time in bed to actual sleep duration (e.g., 6 hours if that is what you currently sleep). Expand gradually as sleep efficiency improves above 85 percent.
- Fixed Rise Time: Get up at the same time every day regardless of how well you slept. The consistency anchors the circadian system.
- Address Daytime Hyperarousal: Caffeine, late-evening exercise, light exposure timing all contribute. Reducing daytime arousal pays off at night.
- Consider Formal CBT-I: Several digital CBT-I programmes (Somryst, Sleepio) have FDA clearance and produce measurable outcomes comparable to in-person therapy for moderate insomnia.
Conclusion: Sleep Is the Absence of Effort, Not Its Reward
The reframing of chronic insomnia from a sleep-failure disorder to a hyperarousal-state disorder is one of the more consequential shifts in modern sleep medicine. The interventions that follow — sleep restriction, stimulus control, cognitive restructuring — are unromantic, uncomfortable in the short term, and substantially more effective than the medications that dominate the consumer conversation. The reader who treats sleep as a state to be achieved through effort is, on the data, sustaining the very arousal that prevents it.
Are you trying to fall asleep — or are you reducing the arousal that, on the data, is what was actually keeping you awake?